Literature DB >> 24855053

Endothelial cell-specific expression of roundabout 4 is regulated by differential DNA methylation of the proximal promoter.

Yoshiaki Okada1, Nobuaki Funahashi2, Toru Tanaka2, Yuji Nishiyama2, Lei Yuan2, Keisuke Shirakura2, Alexis S Turjman2, Yoshihiro Kano2, Hiroki Naruse2, Ayano Suzuki2, Miki Sakai2, Jiang Zhixia2, Kenji Kitajima2, Kenji Ishimoto2, Nobumasa Hino2, Masuo Kondoh2, Yohei Mukai2, Shinsaku Nakagawa2, Guillermo García-Cardeña2, William C Aird1, Takefumi Doi2.   

Abstract

OBJECTIVE: The molecular basis of endothelial cell (EC)-specific gene expression is poorly understood. Roundabout 4 (Robo4) is expressed exclusively in ECs. We previously reported that the 3-kb 5'-flanking region of the human Robo4 gene contains information for lineage-specific expression in the ECs. Our studies implicated a critical role for GA-binding protein and specificity protein 1 (SP1) in mediating overall expression levels. However, these transcription factors are also expressed in non-ECs. In this study, we tested the hypothesis that epigenetic mechanisms contribute to EC-specific Robo4 gene expression. METHODS AND
RESULTS: Bisulfite sequencing analysis indicated that the proximal promoter of Robo4 is methylated in non-ECs but not in ECs. Treatment with the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine increased Robo4 gene expression in non-ECs but not in ECs. Proximal promoter methylation significantly decreased the promoter activity in ECs. Electrophoretic mobility shift assays showed that DNA methylation of the proximal promoter inhibited SP1 binding to the -42 SP1 site. In DNase hypersensitivity assays, chromatin condensation of the Robo4 promoter was observed in some but not all nonexpressing cell types. In Hprt (hypoxanthine phosphoribosyltransferase)-targeted mice, a 0.3-kb proximal promoter directed cell-type-specific expression in the endothelium. Bisulfite sequencing analysis using embryonic stem cell-derived mesodermal cells and ECs indicated that the EC-specific methylation pattern of the promoter is determined by demethylation during differentiation and that binding of GA-binding protein and SP1 to the proximal promoter is not essential for demethylation.
CONCLUSIONS: The EC-specific DNA methylation pattern of the Robo4 proximal promoter is determined during cell differentiation and contributes to regulation of EC-specific Robo4 gene expression.
© 2014 American Heart Association, Inc.

Entities:  

Keywords:  DNA methylation; endothelial cells; epigenomics

Mesh:

Substances:

Year:  2014        PMID: 24855053      PMCID: PMC5378492          DOI: 10.1161/ATVBAHA.114.303818

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  21 in total

1.  Magic roundabout is a new member of the roundabout receptor family that is endothelial specific and expressed at sites of active angiogenesis.

Authors:  Lukasz Huminiecki; Michael Gorn; Steven Suchting; Richard Poulsom; Roy Bicknell
Journal:  Genomics       Date:  2002-04       Impact factor: 5.736

2.  Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD.

Authors:  H Weintraub; S J Tapscott; R L Davis; M J Thayer; M A Adam; A B Lassar; A D Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

3.  roundabout4 is essential for angiogenesis in vivo.

Authors:  Victoria M Bedell; Sang-Yeob Yeo; Kye Won Park; Jeffrey Chung; Pankaj Seth; Venkatesha Shivalingappa; Jinhua Zhao; Tomoko Obara; Vikas P Sukhatme; Iain A Drummond; Dean Y Li; Ramani Ramchandran
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-22       Impact factor: 11.205

Review 4.  Epigenetics of the vascular endothelium.

Authors:  Matthew Shu-Ching Yan; Charles C Matouk; Philip A Marsden
Journal:  J Appl Physiol (1985)       Date:  2010-04-22

5.  Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability.

Authors:  Christopher A Jones; Nyall R London; Haoyu Chen; Kye Won Park; Dominique Sauvaget; Rebecca A Stockton; Joshua D Wythe; Wonhee Suh; Frederic Larrieu-Lahargue; Yoh-Suke Mukouyama; Per Lindblom; Pankaj Seth; Antonio Frias; Naoyuki Nishiya; Mark H Ginsberg; Holger Gerhardt; Kang Zhang; Dean Y Li
Journal:  Nat Med       Date:  2008-03-16       Impact factor: 53.440

6.  A three-kilobase fragment of the human Robo4 promoter directs cell type-specific expression in endothelium.

Authors:  Yoshiaki Okada; Kiichiro Yano; Enjing Jin; Nobuaki Funahashi; Mie Kitayama; Takefumi Doi; Katherine Spokes; David L Beeler; Shu-Ching Shih; Hitomi Okada; Tatyana A Danilov; Elizabeth Maynard; Takashi Minami; Peter Oettgen; William C Aird
Journal:  Circ Res       Date:  2007-05-10       Impact factor: 17.367

7.  Robo4 is a vascular-specific receptor that inhibits endothelial migration.

Authors:  Kye Won Park; Clayton M Morrison; Lise K Sorensen; Christopher A Jones; Yi Rao; Chi-Bin Chien; Jane Y Wu; Lisa D Urness; Dean Y Li
Journal:  Dev Biol       Date:  2003-09-01       Impact factor: 3.582

8.  Oxygen-regulated erythropoietin gene expression is dependent on a CpG methylation-free hypoxia-inducible factor-1 DNA-binding site.

Authors:  R H Wenger; I Kvietikova; A Rolfs; G Camenisch; M Gassmann
Journal:  Eur J Biochem       Date:  1998-05-01

9.  A GABP-binding element in the Robo4 promoter is necessary for endothelial expression in vivo.

Authors:  Yoshiaki Okada; Enjing Jin; Vesna Nikolova-Krstevski; Kiichiro Yano; Ju Liu; David Beeler; Katherine Spokes; Mie Kitayama; Nobuaki Funahashi; Takefumi Doi; Lauren Janes; Takashi Minami; Peter Oettgen; William C Aird
Journal:  Blood       Date:  2008-06-02       Impact factor: 22.113

10.  Identification and angiogenic role of the novel tumor endothelial marker CLEC14A.

Authors:  M Mura; R K Swain; X Zhuang; H Vorschmitt; G Reynolds; S Durant; J F J Beesley; J M J Herbert; H Sheldon; M Andre; S Sanderson; K Glen; N-T Luu; H M McGettrick; P Antczak; F Falciani; G B Nash; Z S Nagy; R Bicknell
Journal:  Oncogene       Date:  2011-06-27       Impact factor: 9.867

View more
  7 in total

Review 1.  The role of epigenetics in the endothelial cell shear stress response and atherosclerosis.

Authors:  Jessilyn Dunn; Rachel Simmons; Salim Thabet; Hanjoong Jo
Journal:  Int J Biochem Cell Biol       Date:  2015-05-13       Impact factor: 5.085

2.  Deletion of Robo4 prevents high-fat diet-induced adipose artery and systemic metabolic dysfunction.

Authors:  Tam T T Phuong; Ashley E Walker; Grant D Henson; Daniel R Machin; Dean Y Li; Anthony J Donato; Lisa A Lesniewski
Journal:  Microcirculation       Date:  2019-04-05       Impact factor: 2.628

3.  HDAC inhibitor, MS-275, increases vascular permeability by suppressing Robo4 expression in endothelial cells.

Authors:  Taito Kashio; Keisuke Shirakura; Mayumi Kinoshita; Maaya Morita; Ryosuke Ishiba; Kosuke Muraoka; Tomoaki Kanbara; Masato Tanaka; Risa Funatsu; Nobumasa Hino; Shohei Koyama; Ryo Suzuki; Yasuo Yoshioka; Taiki Aoshi; Takefumi Doi; Yoshiaki Okada
Journal:  Tissue Barriers       Date:  2021-05-06

4.  Enhanced ROBO4 is mediated by up-regulation of HIF-1α/SP1 or reduction in miR-125b-5p/miR-146a-5p in diabetic retinopathy.

Authors:  Qiaoyun Gong; Jia'nan Xie; Ying Li; Yang Liu; Guanfang Su
Journal:  J Cell Mol Med       Date:  2019-05-15       Impact factor: 5.310

Review 5.  Regulatory mechanisms of Robo4 and their effects on angiogenesis.

Authors:  Chang Dai; Qiaoyun Gong; Yan Cheng; Guanfang Su
Journal:  Biosci Rep       Date:  2019-07-10       Impact factor: 3.840

6.  miR-140-5p regulates vascular smooth muscle cell viability, migration and apoptosis by targeting ROBO4 gene expression in atherosclerosis.

Authors:  Yi Luo; Yangmin Li; Hong Peng; Yu Zhao
Journal:  Mol Med Rep       Date:  2021-01-26       Impact factor: 2.952

7.  ETV2-TET1/TET2 Complexes Induce Endothelial Cell-Specific Robo4 Expression via Promoter Demethylation.

Authors:  Toru Tanaka; Kohei Izawa; Yusuke Maniwa; Maki Okamura; Atsumasa Okada; Tomoko Yamaguchi; Keisuke Shirakura; Naoki Maekawa; Hayato Matsui; Kenji Ishimoto; Nobumasa Hino; Osamu Nakagawa; William C Aird; Hiroyuki Mizuguchi; Kenji Kawabata; Takefumi Doi; Yoshiaki Okada
Journal:  Sci Rep       Date:  2018-04-04       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.